MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Net Income
-$6,571,342
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Grant revenue
0
0
8,726
322,569
Research and development
4,321,772
5,135,419
5,830,207
6,040,442
General and administrative
2,356,779
2,975,105
2,510,038
2,326,326
Total operating expenses
6,678,551
8,110,524
8,340,245
8,366,768
Loss from operations
-6,678,551
-8,110,524
-8,331,519
-8,044,199
Other expense
1,998
-1,021
3,291
-1,227
Interest income
104,897
147,387
240,938
318,787
Total other income, net
106,895
146,366
244,229
317,560
Net loss
-6,571,656
-7,964,158
-8,087,290
-7,726,639
Net unrealized loss on marketable securities
314
-6,024
-8
6,607
Total comprehensive loss
-6,571,342
-7,970,182
-8,087,298
-7,720,032
Basic EPS
-0.64
-0.86
-0.873
-0.84
Basic Average Shares
10,244,516
9,258,319
9,261,081
9,252,719
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Total comprehensive
loss
-$6,571,342
(-4.63%↓ Y/Y)
Net unrealized loss
on marketable...
$314
(101.43%↑ Y/Y)
Interest income
$104,897
(-71.51%↓ Y/Y)
Other expense
$1,998
(119.48%↑ Y/Y)
Net loss
-$6,571,656
(-5.01%↓ Y/Y)
Total other income,
net
$106,895
(-70.13%↓ Y/Y)
Loss from operations
-$6,678,551
(-0.94%↓ Y/Y)
Total operating
expenses
$6,678,551
(-20.25%↓ Y/Y)
Research and development
$4,321,772
(-15.40%↓ Y/Y)
General and
administrative
$2,356,779
(-27.83%↓ Y/Y)
Buy us a coffee
CervoMed Inc. (CRVO)
CervoMed Inc. (CRVO)